MAGE-TAB Version 1.1 Comment[MetaboBank accession] MTBKS285 Study Title Hepatic metabolome analysis of acute high-protein feeding in non-diabetic and diabetic mice Study Description Acute high-protein feeding alters amino acid metabolism through changes in insulin and glucagon secretion, but its effects on hepatic metabolism under non-diabetic and diabetic conditions remain unclear. In this study, non-diabetic (ND) and streptozotocin-induced diabetic (STZ-D) C57BL/6J mice were fasted for 16 hours and administered either a liquid normal control (LNC) diet or a liquid high-protein (LHP) diet. Liver tissue samples (30 mg) collected 2 hours post-feeding were analyzed using capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS) in both positive and negative ion modes to quantify intrahepatic metabolites, including amino acids and glycolytic/gluconeogenic intermediates. Acute high-protein feeding induced marked hepatic accumulation of amino acids specifically in STZ-D mice. On the other hand, glycolytic metabolite levels showed no significant differences between the LNC and LHP groups in either ND or STZ-D mice. However, STZ-D mice exhibited significantly higher concentrations of the initial glycolytic metabolites-glucose 1-phosphate, glucose 6-phosphate, and fructose 6-phosphate- compared to ND mice. Experimental Design disease state design stimulus or stress design Experimental Factor Name disease_state diet Experimental Factor Type disease_state diet Person Last Name Seino Hidaka Person First Name Yusuke Shihomi Person Mid Initials Person Affiliation Department of Endocrinology, Diabetes and Metabolism,, Fujita Health University, School of Medicine Department of Endocrinology, Diabetes and Metabolism,, Fujita Health University, School of Medicine Person Roles submitter submitter PubMed ID Publication DOI Protocol Name Sample collection Extraction Capillary Electrophoresis Mass spectrometry Data processing Metabolite identification Protocol Type Sample collection Extraction Capillary Electrophoresis Mass spectrometry Data processing Metabolite identification Protocol Description Eight-week-old male C57BL/6J mice were assigned to two groups: ND and STZ-D mice. To induce diabetes, mice received intraperitoneal injections of STZ (50 mg/kg) for five consecutive days. Control mice were injected with saline for five consecutive days. After 11-day interval from the final injection, the mice were fasted for 16 hours and then administered a liquid diet.The Control diet group(LNC) received a diet adjusted to 67.0% carbohydrate, 14.6% protein, and 18.4% fat (2.19 kcal/mL) . The High Protein Diet group(LHP) received a diet supplemented with SAVAS protein(Meiji Co., Ltd.),resulting in a final composition of 23.4% carbohydrate, 58.2% protein, and 18.4% fat (2.18 kcal/mL). Mice were euthanized by inhalation of 5% isoflurane and sacrificed 2 hours after feeding and liver samples were collected. For extraction of the metabolites, samples were supplemented with 100 μL ultrapure water,80 μL of diluted (1:640) internal standard (Human Metabolome Technologies, Yamagata, Japan, Cat# H3304-1002), 465 μL of methanol, and 465 μL of chloroform. The samples were then homogenized using a pre-cooled bead crusher at 3200 rpm for 1 min and centrifuged at 15 000 × g at 4°C for 10 min. The aqueous layer was transferred to pre-wetted ultrafiltration tubes (Human Metabolome Technologies, Cat No. UFC3LCCNB-HMT) and centrifuged at 9100 × g, 4°C until completely filtrated. The filtrate was freeze-dried, re-dissolved in 50 μL of water, and subjected to mass spectrometry. All separations were performed using a G7100A capillary electrophoresis system (Agilent Technologies, Santa Clara, CA, USA) equipped with fused silica capillaries (Human Metabolome Technologies, Cat. No. H3305-2002). Separations were carried out at 25°C using the cation analysis buffer and anion analysis buffer (Human Metabolome Technologies, Cat. No. H3301-1001, H3302-2021) as the background electrolytes. Metabolites were analyzed using a G6224A time-of-flight LC/MS mass spectrometer (Agilent Technologies) interfaced with the G7100A capillary electrophoresis system.A G1310A isocratic pump (Agilent Technologies) equipped with a G1379B degasser (Agilent Technologies) was used to deliver sheath liquid (Human Metabolome Technologies, Cat. No. H3301-2020) to the electrospray nebulizer at a flow rate of 1.0 mL/min. The mass spectrometer was operated in both positive and negative ionization modes. Chromatograms and mass spectra were analyzed using MassHunter Qualitative Analysis version 10.0 s (Agilent Technologies; RRID:SCR_015040). Annotation and quantification of chromatogram peaks were performed using a standard mixture(Human Metabolome Technologies, Cat. No. H3304-1031, H3304-1032, H3304-1034, H3304-1036).The identified metabolites were normalized to tissue weight. Protocol Parameters Post extraction;Derivatization CE instrument;Autosampler model;Column model;Column type Scan polarity;Scan m/z range;Instrument;Ion source;Mass analyzer Protocol Hardware Protocol Software Public Release Date 2026-09-08 Term Source Name Term Source File Term Source Version SDRF File MTBKS285.sdrf.txt Comment[Study type] targeted metabolite profiling Comment[Experiment type] capillary electrophoresis-mass spectrometry Comment[Submission type] CE-MS Comment[BioProject] PRJDB42820 Comment[Related study] Comment[Contributor] Comment[Submission Date] 2026-08-13 Comment[Last Update Date] 2026-09-08